Geoffrey Chong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Hodgkin Lymphoma

Quality Improvement

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Yoon Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Samuel Opat, Eliza A Hawkes
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project. EJHaem 5 (2) (2024)
Shin Hnin Wai, Sze Ting Lee, Edward Robert Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A Hawkes, Geoffrey Chong
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood advances 8 (3) (2024)
Shin Hnin Wai, Sze Ting Lee, Edward Robert Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A Hawkes, Geoffrey Chong
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood advances 8 (3) (2024)
Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Yoon Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Samuel Opat, Eliza A Hawkes
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project. EJHaem 5 (2) (2024)
Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Yoon Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Samuel Opat, Eliza A Hawkes
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project. EJHaem 5 (2) (2024)
Shin Hnin Wai, Sze Ting Lee, Edward Robert Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A Hawkes, Geoffrey Chong
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood advances 8 (3) (2024)
Shin Hnin Wai, Sze-Ting Lee, Edward Robert Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A Hawkes, Geoffrey Chong
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood advances (2023)